Restore Medical

Israel - Or Yehuda

• 09/07/2025
• Series B
• $23,000,000

Our mission at Restore Medical is to provide a unique solution for patients with congestive heart failure (CHF). CHF is one of the leading causes of death and hospitalization, affecting millions worldwide. Patients remain with disabling symptoms despite receiving currently-available optimized medical treatment. To that end, we have developed ContraBand™, a novel catheter-delivered implant which aims to improve CHF patients’ quality-of-life and reduce hospital readmission rates.

Related People

Gilad MaromFounder

Israel - ND

As the CEO of Restore Medical, I bring extensive experience in managing medical devices, including the development of several successful cardiovascular implants. With a proven track record in the industry, I possess the leadership skills, technical expertise, and business acumen needed to drive growth and innovation. I have experience in managing joint US-Israel operations, which has honed my ability to navigate complex cross-cultural and international business environments. I am passionate about delivering cutting-edge solutions to improve patient outcomes and passionate about the medical device industry. My goal is to continue building a company that delivers meaningful impact and is at the forefront of medical technology.

LinkedIn https://www.linkedin.com/in/gilad-marom-136a881/